Rare diseases
Investigational molecules
Locations
Study on Alnuctamab and Mezigdomide for Patients with Relapsed or Refractory Multiple Myeloma
DenmarkStudy on Dexmedetomidine and Ropivacaine for Pain Relief in Shoulder Surgery Patients
BelgiumStudy of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
BelgiumStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer
BelgiumGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
AustriaStudy of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer
AustriaEfficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
BelgiumComparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma
PolandStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
FranceStudy on the Effects of Dexamethasone, Tocilizumab, and Anakinra on Inflammation in Healthy Volunteers
The NetherlandsStudy on the Safety and Effectiveness of Anitocabtagene Autoleucel and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
